Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic Approach to the Patients with Suspected Primary Immunodeficiency.
Tavakol M, Jamee M, Azizi G, Sadri H, Bagheri Y, Zaki-Dizaji M, Mahdavi FS, Jadidi-Niaragh F, Tajfirooz S, Kamali AN, Aghamahdi F, Noorian S, Kojidi HT, Mosavian M, Matani R, Dolatshahi E, Porrostami K, Elahimehr N, Fatemi-Abhari M, Sharifi L, Arjmand R, Haghi S, Zainaldain H, Yazdani R, Shaghaghi M, Abolhassani H, Aghamohammadi A. Tavakol M, et al. Among authors: bagheri y. Endocr Metab Immune Disord Drug Targets. 2020;20(2):157-171. doi: 10.2174/1871530319666190828125316. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 31456526 Review.
The Clinical and Immunological Features of Patients with Primary Antibody Deficiencies.
Azizi G, Bagheri Y, Tavakol M, Askarimoghaddam F, Porrostami K, Rafiemanesh H, Yazdani R, Kiaee F, Habibi S, Abouhamzeh K, Mohammadi H, Qorbani M, Abolhassani H, Aghamohammadi A. Azizi G, et al. Among authors: bagheri y. Endocr Metab Immune Disord Drug Targets. 2018;18(5):537-545. doi: 10.2174/1871530318666180413110216. Endocr Metab Immune Disord Drug Targets. 2018. PMID: 29651973
The profile of IL-4, IL-5, IL-10 and GATA3 in patients with LRBA deficiency and CVID with no known monogenic disease: Association with disease severity.
Azizi G, Bagheri Y, Yazdani R, Zaki-Dizaji M, Jamee M, Jadidi-Niaragh F, Kamali AN, Abolhassani H, Aghamohammadi A. Azizi G, et al. Among authors: bagheri y. Allergol Immunopathol (Madr). 2019 Mar-Apr;47(2):172-178. doi: 10.1016/j.aller.2018.06.003. Epub 2018 Sep 5. Allergol Immunopathol (Madr). 2019. PMID: 30193889
Autoimmunity in a cohort of 471 patients with primary antibody deficiencies.
Azizi G, Tavakol M, Rafiemanesh H, Kiaee F, Yazdani R, Heydari A, Abouhamzeh K, Anvari P, Mohammadikhajehdehi S, Sharifia L, Bagheri Y, Mohammadi H, Abolhassani H, Aghamohammadi A. Azizi G, et al. Among authors: bagheri y. Expert Rev Clin Immunol. 2017 Nov;13(11):1099-1106. doi: 10.1080/1744666X.2017.1384312. Epub 2017 Oct 11. Expert Rev Clin Immunol. 2017. PMID: 29019451
Anti-Inflammatory Effect of KW-2449 on Autoimmune Encephalomyelitis: An Experimental Study on Mice.
Ahmadabad HN, Abbaspour A, Panahi Y, Tahmasebi S, Hossein-Khannazer N, Afraei S, Miladi H, Goudarzvand M, Kamali AN, Bagheri Y, Yazdani R, Di Fiore MM, Azizi G. Ahmadabad HN, et al. Among authors: bagheri y. Endocr Metab Immune Disord Drug Targets. 2021;21(9):1590-1597. doi: 10.2174/1871530320666201106095808. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 33155932
58 results